About Stavropol Regional Clinical Diagnostic Centre
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
ACADIA Pharmaceuticals Inc.
2
Arena Pharmaceuticals
2
Hoffmann-La Roche
2
Pfizer
2
Clinical Trials at Stavropol Regional Clinical Diagnostic Centre
During the past decade, Stavropol Regional Clinical Diagnostic Centre conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease
2020-01-13
2031-08-01
Recruiting
1,115
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Stavropol Regional Clinical Diagnostic Centre"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Stavropol Regional Clinical Diagnostic Centre
According to Clinical.Site data, the most researched conditions in "Stavropol Regional Clinical Diagnostic Centre" are
"Ulcerative Colitis" (5 trials), "Neuropsychiatric Symptoms Related to Neurodegenerative Disease" (2 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Stavropol Regional Clinical Diagnostic Centre" in a lesser frequency.
Clinical Trials Intervention Types at Stavropol Regional Clinical Diagnostic Centre
Most popular intervention types in "Stavropol Regional Clinical Diagnostic Centre" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Etrasimod" (4 trials), "Placebo" (4 trials), "Etrolizumab" (2 trials), "Pimavanserin" (2 trials) and "Adalimumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Stavropol Regional Clinical Diagnostic Centre
The vast majority of trials in "Stavropol Regional Clinical Diagnostic Centre" are
8 trials for "All" genders.
Clinical Trials Status at Stavropol Regional Clinical Diagnostic Centre
Currently, there are NaN active trials in "Stavropol Regional Clinical Diagnostic Centre".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Stavropol Regional Clinical Diagnostic Centre,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Stavropol Regional Clinical Diagnostic Centre, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".